H3.A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.E1.Phone number information was not provided, therefore, (b)(6) was used as a place holder.
|
It was reported that bd inexiva 24ga 0.75in y was difficult to withdraw.The following information was provided by the initial reporter, translated from chinese to english: patient found unable to withdraw the needle core during use, need to use tweezers to twist the tip protector loose before withdrawing, patient bleeding heavily.
|